Trials / Conditions / Metastatic or Locally Advanced Unresectable Solid Tumors
Metastatic or Locally Advanced Unresectable Solid Tumors
4 registered clinical trials studyying Metastatic or Locally Advanced Unresectable Solid Tumors.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor ( NCT05396833 | EMD Serono Research & Development Institute, Inc. | Phase 1 |
| Terminated | First in Human Study of M1069 in Advanced Solid Tumors NCT05198349 | EMD Serono Research & Development Institute, Inc. | Phase 1 |
| Active Not Recruiting | Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Soli NCT04170153 | EMD Serono Research & Development Institute, Inc. | Phase 1 |
| Terminated | First-in-Human Study of MS201408-0005A as Single Agent and in Combinations NCT03306420 | EMD Serono Research & Development Institute, Inc. | Phase 1 |